Pyxis Oncology (PYXS) Assets (2020 - 2026)
Pyxis Oncology (PYXS) posted quarterly Assets of $91.5 million for Q4 2025, down 41.77% year-over-year from $157.2 million in Q4 2024, and down 13.34% quarter-over-quarter from $105.6 million in Q3 2025.
Pyxis Oncology (PYXS) Assets (2020 - 2026) Analysis & Trends
Pyxis Oncology (PYXS) has reported Assets for 6 consecutive years, with $91.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets fell 41.77% year-over-year to $91.5 million; the TTM figure through Dec 2025 stood at $91.5 million (down 41.77% YoY), while the FY2025 annual figure was $91.5 million, down 41.77% from the prior year.
- Assets declined to $91.5 million in Q4 2025 per PYXS's latest filing, from $105.6 million in the prior quarter.
- Across five years, Assets topped out at $280.0 million in Q4 2021 and bottomed at $91.5 million in Q4 2025.
- Historically, Assets has averaged $183.7 million across 5 years, with a median of $184.7 million in 2023.
- Annual changes were most pronounced in 2021 — Assets jumped 2658.56% — and 2025, when it tumbled 45.93%.
- Pyxis Oncology's Assets stood at $280.0 million in 2021, then fell by 24.51% to $211.4 million in 2022, then dropped by 17.81% to $173.7 million in 2023, then dropped by 9.52% to $157.2 million in 2024, then tumbled by 41.77% to $91.5 million in 2025.
- Business Quant data shows PYXS's Assets at $91.5 million in Q4 2025, $105.6 million in Q3 2025, and $123.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Pyxis Oncology | 199.01 Mn | 166.02 Mn | - | 54.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.92 Mn |
| Dec 31, 2025 | 91.52 Mn |
| Sep 30, 2025 | 105.60 Mn |
| Jun 30, 2025 | 123.22 Mn |
| Mar 31, 2025 | 135.87 Mn |
| Dec 31, 2024 | 157.18 Mn |
| Sep 30, 2024 | 195.31 Mn |
| Jun 30, 2024 | 208.39 Mn |
| Mar 31, 2024 | 220.22 Mn |
| Dec 31, 2023 | 173.73 Mn |
| Sep 30, 2023 | 186.69 Mn |
| Jun 30, 2023 | 175.23 Mn |
| Mar 31, 2023 | 182.80 Mn |
| Dec 31, 2022 | 211.38 Mn |
| Sep 30, 2022 | 223.90 Mn |
| Jun 30, 2022 | 242.56 Mn |
| Mar 31, 2022 | 252.70 Mn |
| Dec 31, 2021 | 280.02 Mn |
| Sep 30, 2021 | 139.49 Mn |
| Dec 31, 2020 | 10.15 Mn |